Investigating the effects of dexamethasone on pulmonary surfactant lipids based on lipidomics studies
Biomedical Chromatography · 2024
DOI: 10.1002/bmc.5937 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, 2024. Verfasst von Zhao Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory of Pediatric Respiratory Disease, Institute of Pediatrics, Medical Metabolomics Center, Pediatrics Department, Affiliated Hosp…. Hauptthemen laut MEDLINE: Lipidomics, Dexamethasone, Pulmonary Surfactants, Bronchoalveolar Lavage Fluid. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Young Elite Scientists Sponsorship Program by CACM, Colleges and universities in Jiangsu Province Natural Science Research, National Natural Science Foundation of China.
Abstract (Originalsprache)
Dexamethasone, a glucocorticoid commonly used in pediatric patients, has potent anti‐inflammatory and immunosuppressive properties. However, it is associated with side effects such as reduced lung function and decreased immunity. Pulmonary surfactant lipids are closely linked to lung disease and play a role in reducing surface tension, immune response and antiviral activity. The dysregulation of lipid metabolism is closely associated with lung disease. Hence, untargeted lipidomics may be instrumental in elucidating the effects of dexamethasone on pulmonary surfactant lipids. We obtained surfactant lipid samples from the bronchoalveolar lavage fluid of young mice injected subcutaneously with dexamethasone and conducted a comprehensive lipidomic analysis, comparing them with a control group. We observed a decrease in lipids, such as phosphatidylcholine, phosphatidylglycerol and phosphatidylethanolamine, and an increase in ceramide, fatty acid, diacylglycerol and monoglyceride, which may impact lung health. This study revealed the influence of dexamethasone on pulmonary surfactant lipids, offering new insights into adverse reactions in clinical settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jiangsu Key Laboratory of Pediatric Respiratory Disease, Institute of Pediatrics, Medical Metabolomics Center, Pediatrics Department, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
ORCID-Profile: Lili Lin, Shouchuan Wang
Förderung
- Young Elite Scientists Sponsorship Program by CACM
- Colleges and universities in Jiangsu Province Natural Science Research
- National Natural Science Foundation of China
- Qinglan Project of Jiangsu Province of China
- Natural Science Research of Jiangsu Higher Education Institutions of China
Zitieren
APA
Wang, Z., Li, T., Lin, L., Xiong, Y., Chen, H., Ye, J., Ji, J., & Wang, S. (2024). Investigating the effects of dexamethasone on pulmonary surfactant lipids based on lipidomics studies. Biomedical Chromatography. https://doi.org/10.1002/bmc.5937
Vancouver
Wang Z, Li T, Lin L, Xiong Y, Chen H, Ye J, et al. Investigating the effects of dexamethasone on pulmonary surfactant lipids based on lipidomics studies. Biomedical Chromatography. 2024. doi:10.1002/bmc.5937
BibTeX
@article{Wang2024,
author = {Wang, Zhao and Li, Tao and Lin, Lili and Xiong, Yingcai and Chen, Hui and Ye, Jin and Ji, Jianjian and Wang, Shouchuan},
title = {Investigating the effects of dexamethasone on pulmonary surfactant lipids based on lipidomics studies},
journal = {Biomedical Chromatography},
year = {2024},
doi = {10.1002/bmc.5937}
}
EUVIMED